<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915614</url>
  </required_header>
  <id_info>
    <org_study_id>AAT 2016</org_study_id>
    <nct_id>NCT02915614</nct_id>
  </id_info>
  <brief_title>Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients</brief_title>
  <official_title>Effects of Pulmonary Rehabilitation on Skeletal Muscle Morphology and Metabolism in PiMM vs. PiZZ COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schön Klinik Berchtesgadener Land</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Schön Klinik Berchtesgadener Land</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a former study, the investigator observed significant differences in the response to&#xD;
      pulmonary rehabilitation between COPD patients with the &quot;normal&quot; genetic variant of alpha-1&#xD;
      antitrypsin (PiMM) and those with a homozygous deficient variant (PiZZ) (Jarosch et al.,&#xD;
      2016, DOI: 10.1159/000449509). PiZZ COPD patients showed less improvement in exercise&#xD;
      capacity compared to PiMM patients. This latter finding was mirrored by an increase of&#xD;
      oxidative myofiber type I proportion - that is important for aerobic exercises in daily life&#xD;
      - in PiMM but not PiZZ patients.&#xD;
&#xD;
      Based on this finding of impaired skeletal muscle adaptation, the aim of this study is to&#xD;
      compare the effects of pulmonary rehabilitation including exercise training on a) specific&#xD;
      enzymes of energy metabolism reflecting the oxidative capacity of the skeletal muscle and b)&#xD;
      the analogue gene expression of these oxidative enzymes in a cohort of PiMM and PiZZ COPD&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2017</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endurance time</measure>
    <time_frame>3 weeks</time_frame>
    <description>Will be measured during a constant work rate cycling test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myofibre type I Distribution</measure>
    <time_frame>3 weeks</time_frame>
    <description>Skeletal muscle sample will be taken from the M.vastus lateralis via Bergström muscle biopsy needle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capillary to fibre ratio</measure>
    <time_frame>3 weeks</time_frame>
    <description>Skeletal muscle sample will be taken from the M.vastus lateralis via Bergström muscle biopsy needle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle strength</measure>
    <time_frame>3 weeks</time_frame>
    <description>strength test in the right knee Extensor and flexor</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>PiMM patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>COPD patients with the Alpha-1 antitrypsin genetic variant &quot;PiMM&quot; (Smoking-related COPD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PiZZ patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients with alpha-1 antitrypsin deficiency (genotype PiZZ)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary rehabilitation</intervention_name>
    <description>3-weeks of inpatient pulmonary Rehabilitation including exercise Training (daily endurance and strength Training)</description>
    <arm_group_label>PiMM patients</arm_group_label>
    <arm_group_label>PiZZ patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease&#xD;
&#xD;
          -  phenotype PiMM or PiZZ&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any comorbidities that prevent patients from participating in an exercise Training&#xD;
             program&#xD;
&#xD;
          -  necessity of anticoagulant therapy&#xD;
&#xD;
          -  other genetic variants of alpha-1 antitrypsin than PiMM or PiZZ&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Kenn, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of respiratory medicine, Schoen Klinik Berchtesgadener Land</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inga Jarosch</last_name>
    <phone>+49865293</phone>
    <phone_ext>1730</phone_ext>
    <email>ijarosch@schoen-kliniken.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Schoen Klinik Berchtesgadener Land</name>
      <address>
        <city>Schönau Am Königssee</city>
        <zip>83471</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inga Jarosch</last_name>
      <phone>0049-8652-931730</phone>
      <email>ijarosch@schoen-kliniken.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 21, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2016</study_first_posted>
  <last_update_submitted>October 12, 2020</last_update_submitted>
  <last_update_submitted_qc>October 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Schön Klinik Berchtesgadener Land</investigator_affiliation>
    <investigator_full_name>Klaus Kenn</investigator_full_name>
    <investigator_title>Head physician, Department of Respiratory Medicine</investigator_title>
  </responsible_party>
  <keyword>alpha-1 antitrypsin deficiency</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>exercise training</keyword>
  <keyword>skeletal muscle biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

